8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.

Noninvasive Brain Stimulation Protects Cognitive Impairment in i.c.v. STZ-Injected Rats: Role of Adult Neurogenesis

Bioeffects Seen

Kumar A, Roy A, Karaddi V, Jain S, Katyal J, Gupta YK · 2025

Share:

Noninvasive extremely low-frequency magnetic field stimulation may protect against cognitive impairment in an animal model of Alzheimer's disease by promoting adult neurogenesis and reducing neuroinflammation.

Plain English Summary

Summary written for general audiences

This study investigated whether extremely low-frequency magnetic field stimulation (17.96 μT, 50 Hz, 2 hours daily for 2 weeks) could improve cognitive function in rats with streptozotocin-induced Alzheimer's-like dementia. The researchers found that the magnetic field stimulation improved spatial and reference memory, stimulated adult neurogenesis in the brain, reduced oxidative stress, and provided neuroprotection in key brain regions including the hippocampus and prefrontal cortex.

Why This Matters

Adult neurogenesis in the hippocampus is known to decline with age and in neurodegenerative diseases, making it a potential therapeutic target for dementia. This study proposes a non-pharmacological mechanism through which magnetic field stimulation could influence neural stem cell activity, though further research would be needed to determine translational relevance to human disease.

Exposure Information

Specific exposure levels were not quantified in this study.

Watch: Video About This Study

Cite This Study
Kumar A, Roy A, Karaddi V, Jain S, Katyal J, Gupta YK (2025). Noninvasive Brain Stimulation Protects Cognitive Impairment in i.c.v. STZ-Injected Rats: Role of Adult Neurogenesis.
Show BibTeX
@article{noninvasive_brain_stimulation_protects_cognitive_impairment_in_icv_stz_injected_rats_role_of_adult_neurogenesis_ce4447,
  author = {Kumar A and Roy A and Karaddi V and Jain S and Katyal J and Gupta YK},
  title = {Noninvasive Brain Stimulation Protects Cognitive Impairment in i.c.v. STZ-Injected Rats: Role of Adult Neurogenesis},
  year = {2025},
  doi = {10.1038/s41588-025-02153-x},
  
}

Quick Questions About This Study

This rat study found that noninvasive electromagnetic brain stimulation helped protect memory and cognitive function in animals with experimentally induced Alzheimer's-like symptoms, primarily by promoting the growth of new brain cells in memory-critical regions.
The electromagnetic stimulation appears to activate cellular pathways that encourage the development of new neurons in adult brains, particularly in areas important for learning and memory formation, helping compensate for disease-related brain cell loss.
Yes, therapeutic electromagnetic brain stimulation uses precisely controlled frequencies, timing, and intensity specifically designed to work with brain physiology, unlike the uncontrolled mix of EMF frequencies emitted by consumer wireless devices and appliances.
Intracerebroventricular STZ injection creates brain changes that mimic Alzheimer's disease, including memory loss, reduced brain metabolism, and neuronal damage, making it a widely used research model for testing potential dementia treatments.
While these rat results are promising, human applications would require extensive clinical trials to determine safe and effective protocols. The study suggests electromagnetic therapy might complement other dementia treatments by protecting existing neurons.